Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

359 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hepatitis C virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and prevention.
Wiessing L, Ferri M, Grady B, Kantzanou M, Sperle I, Cullen KJ; EMCDDA DRID group; Hatzakis A, Prins M, Vickerman P, Lazarus JV, Hope VD, Matheï C. Wiessing L, et al. Among authors: lazarus jv. PLoS One. 2014 Jul 28;9(7):e103345. doi: 10.1371/journal.pone.0103345. eCollection 2014. PLoS One. 2014. PMID: 25068274 Free PMC article. Review.
Roundtable discussion: how lessons learned from HIV can inform the global response to viral hepatitis.
Lazarus JV, Lundgren J, Casabona J, Wiessing L, Matheï C, Vickerman P, Prins M, Kretzschmar M, Kantzanou M, Giraudon I, Ferri M, Griffiths P, Harris M, Walker M, Chavdarova L, Schatz E, Schiffer K, Kools J, Farell J, Mendão L. Lazarus JV, et al. BMC Infect Dis. 2014;14 Suppl 6(Suppl 6):S18. doi: 10.1186/1471-2334-14-S6-S18. Epub 2014 Sep 19. BMC Infect Dis. 2014. PMID: 25252919 Free PMC article. No abstract available.
Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs.
Grebely J, Bruneau J, Lazarus JV, Dalgard O, Bruggmann P, Treloar C, Hickman M, Hellard M, Roberts T, Crooks L, Midgard H, Larney S, Degenhardt L, Alho H, Byrne J, Dillon JF, Feld JJ, Foster G, Goldberg D, Lloyd AR, Reimer J, Robaeys G, Torrens M, Wright N, Maremmani I, Norton BL, Litwin AH, Dore GJ; International Network on Hepatitis in Substance Users. Grebely J, et al. Among authors: lazarus jv. Int J Drug Policy. 2017 Sep;47:51-60. doi: 10.1016/j.drugpo.2017.05.019. Epub 2017 Jul 3. Int J Drug Policy. 2017. PMID: 28683982 Free PMC article.
Late presentation of chronic viral hepatitis for medical care: a consensus definition.
Mauss S, Pol S, Buti M, Duffell E, Gore C, Lazarus JV, der Grient HL, Lundgren J, Mozalevskis A, Raben D, Schatz E, Wiktor S, Rockstroh JK; European consensus working group on late presentation for Viral Hepatitis Care. Mauss S, et al. Among authors: lazarus jv. BMC Med. 2017 May 3;15(1):92. doi: 10.1186/s12916-017-0856-y. BMC Med. 2017. PMID: 28464883 Free PMC article.
Restrictions on access to direct-acting antivirals for people who inject drugs: The European Hep-CORE study and the role of patient groups in monitoring national HCV responses.
Lazarus JV, Safreed-Harmon K, Stumo SR, Jauffret-Roustide M, Maticic M, Reic T, Schatz E, Tallada J, Harris M; Hep-CORE Study Group. Lazarus JV, et al. Int J Drug Policy. 2017 Sep;47:47-50. doi: 10.1016/j.drugpo.2017.05.054. Epub 2017 Jul 6. Int J Drug Policy. 2017. PMID: 28689856 No abstract available.
359 results